Screener / SEC EDGAR /CIK 0001723128 /10-K filed Feb 27, 2026, compared with Feb 28, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Pharmaceuticals

Amneal Pharmaceuticals, Inc. AMRX

Compare with peers Embed
CEO pay, fiscal year to Dec 31, 2025

Chirag Patel, Chintu Patel was paid $17.4M as reported, $48.7M at the share price

Proxy (DEF 14A)
CEO pay, as reported $17.4M salary, bonus and awards at grant value
CEO pay, actually paid $48.7M awards valued at the share price
$100 in the shares became $276 peer group: $156
CEO pay, 5 years $56.2M up 82% while net income rose 540%

Did pay move with results?

Each line is 100 in 2021 · pay versus performance table, proxy (DEF 14A)

-75007501500 20212022202320242025 CEO pay, 2021: 100CEO pay, 2022: -131CEO pay, 2023: 680CEO pay, 2024: 852CEO pay, 2025: 1750 CEO pay 1750 Net income, 2021: 100Net income, 2022: -1275Net income, 2023: -245Net income, 2024: -370Net income, 2025: 640 Net income 640 $100 invested, 2021: 100$100 invested, 2022: 42$100 invested, 2023: 127$100 invested, 2024: 165$100 invested, 2025: 263 $100 invested 263

When the pay line climbs faster than net income and the $100 line, pay rose more than results did; when it falls with them, it followed them. "Actually paid" re-values stock awards at the share price, so it moves with the stock. Numbers as the company tagged them in its proxy.

Pay against results, year by year

Pay versus performance · proxy, filed Mar 25, 2026

Fiscal year toCEOCEO pay (reported) CEO pay (actually paid) $100 became
Dec 31, 2025Chirag Patel, Chintu Patel $17.4M$48.7M $276
Dec 31, 2024Chirag Patel, Chintu Patel $14.4M$23.7M $173
Dec 31, 2023Chirag Patel, Chintu Patel $4.7M$18.9M $133
Dec 31, 2022Chirag Patel, Chintu Patel $10.1M-$3.7M $44
Dec 31, 2021Chirag Patel, Chintu Patel $9.6M$2.8M $105

Pay versus performance table of the proxy statement (DEF 14A) filed Mar 25, 2026, as tagged by the company in XBRL. Open the proxy

Pay against free cash flow per share, at peers

Change over the years each proxy covers · pay versus performance table, DEF 14A, and 10-K XBRL

CEO pay, as reported Free cash flow per share » runs past the edge. Pay is salary, bonus and awards at grant value. FCF per share is cash from operations less capital spending, over diluted shares, from the 10-K of the same fiscal year.

AMRX: CEO pay rose 82% from FY2021 to FY2025 ($9.6M to $17.4M), while free cash flow per share fell 35% ($1.28 to $0.83). Open the proxy

Sources

The pay versus performance table of the latest proxy statement, as the company tagged it in XBRL.

Also

Cash & buybacks: what the company did with its cash in the same years.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/AMRX/export.csv") into a cell.

Next:Crypto holdings
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.